Daan Gene Co., Ltd.

Symbol: 002030.SZ

SHZ

10.03

CNY

Market price today

  • 16.3617

    P/E Ratio

  • 0.3298

    PEG Ratio

  • 13.75B

    MRK Cap

  • 0.17%

    DIV Yield

Daan Gene Co., Ltd. (002030-SZ) Stock Split, History Data

Working capital analysis

In terms of working capital, Daan Gene Co., Ltd. maintains a healthy position. The total current assets of the company are valued at $8768965309.92. This represents a growth rate of 46.516% compared to the previous year. Breaking down the current assets, the cash and investments are worth $2594441248.01, exhibiting a growth rate of 19.067% year-on-year. The receivables, another significant portion of the current assets, are valued at $4497405092.91. The year-on-year growth rate for receivables is 64.681%. The inventory, which forms a critical part of the assets, is valued at $369595648.95. This represents a healthy year-on-year growth of -25.140% On the liabilities side, the company's current liabilities total $2968742968.32. This reflects a growth rate of 17.758% over the previous year, indicating the company's financial obligations are well under control.

202220212020201920182017
Cash and investments
2594.44
2178.98
870.40
227.06
385.84
1257.55
Receavebles
4497.41
2730.97
1910.82
998.99
1005.17
1059.39
Inventory
369.60
493.72
315.72
185.00
161.31
203.23
Other
826.63
201.30
342.40
300.26
562.25
685.03
Total Current Assets
8768.97
5984.98
4327.33
1751.55
2114.57
3205.20
Acc Payable
737.07
553.01
474.92
128.52
109.23
205.04
Short Term Debt
157.93
305.08
386.72
722.82
982.20
931.30
Other Current Liab
2073.74
27.79
26.32
79.33
288.15
287.18
Current Liabilities
2968.74
2521.04
2064.46
1115.75
1379.58
1589.68

Capital Structure

When examining the capital structure of Daan Gene Co., Ltd., it is clear that the company manages a robust portfolio. The value of their total assets clocks in at $11310013290.86. When juxtaposed with the previous year, this marks a growth rate of -18.331%, showcasing the company's ability to steadily grow its asset base. Turning to liabilities, the company has total liabilities amounting to $1864144034.96. Compared to the prior year, this reflects a growth rate of -30.778%. The long-term debt forms a sizable part of these liabilities, coming in at $32341116.88. Over the last year, the long-term debt has grown by -43.691%. On the asset side, the cash and equivalent reserves are worth $1004545766.32. The year-on-year growth of these reserves is -50.109%. The company's common stock, another important asset, holds a value of $1403446032, growing at a rate of 0.000% from the previous year. Finally, the company's retained earnings stand at $5826924882.22, marking a growth rate of -26.943% year-over-year. These earnings represent the profits that Daan Gene Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$11,310.01

Total liabilities

$1,864,144,034.96

Long term debt

$32.34

Cash and eqv

$1,004,545,766.32

Goodwill

$0.00

Retained earnings

$5,826,924,882.22

Common stock

$61.60

Enterprise Value

$10.85

Historical dividend key summary

Daan Gene Co., Ltd.'s dividend per share is $1.75, showing the earnings shared with shareholders per share. It has grown by 57.658% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.

YearsQ1Q2Q3Q4Total
20230.0001.7500.0000.0001.750
20220.0001.1100.0000.0001.110
20210.0000.3440.0000.0000.344
20200.0000.0160.0000.0000.016
20190.0000.0230.0000.0000.023
20180.0000.0130.0000.0000.013
20170.0000.0230.0000.0000.023
20160.0000.0130.0000.0000.013
20150.0000.0200.0000.0000.020
20140.0000.0000.0070.0000.007
20130.0000.0040.0000.0000.004
20120.0000.0060.0000.0000.006
20110.0000.0020.0000.0000.002
20100.0000.0050.0000.0000.005
20090.0000.0050.0000.0000.005
20080.0000.0140.0000.0000.014
20070.0000.0130.0000.0000.013
20060.0000.0180.0000.0000.018
20050.0000.0110.0000.0000.011

Daan Gene Co., Ltd. (002030.SZ) stock split history

Understanding the historical stock splits of Daan Gene Co., Ltd. (002030.SZ) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on May 19, 2021 with a ratio of 1.6:1. Throughout its history, the company has undergone 12 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.

DateSplit Ratio
19 May 20211.6:1
18 June 20201.1:1
15 June 20181.1:1
21 June 201611:10
17 June 201512:10
15 July 201412:10
19 June 20131.1:1
15 June 201212:10
17 June 201112:10
10 June 200912:10
14 May 200816:10
17 May 200615:10

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is 0.282.

What is company revenue per share?

The company revenue per share is 0.248.

What are firm earnings per share?

The firm earnings per share is 0.978.

What is Daan Gene Co., Ltd. (002030.SZ) ROIC (return on capital)?

Daan Gene Co., Ltd. (002030.SZ) ROIC (return on capital) is 0.092.

What is dividend per share figure?

The dividend per share is 1.750

What is enterprise plowback ratio?

Daan Gene Co., Ltd. (002030.SZ) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is 10.851

What is company debt to equity ratio?

The debt to equity ratio is 0.037

What are debt ratio numbers?

The debt ratio is 0.030

What is company price to sales ratio?

The price to sales ratio is 3.871